Rapid trafficking of membrane type 1-matrix metalloproteinase to the cell surface regulates progelatinase A activation

Laboratory Investigation

Volumn 82, Issue 12, 2002, Pages 1673-1684

  Zucker, Stanley ^a,b   Hymowitz, Michelle ^a   Conner, Cathleen E ^a   DiYanni, Elizabeth A ^a   Cao, Jian ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIUM CHLORIDE; BAFILOMYCIN A1; CELL SURFACE RECEPTOR; CHLOROQUINE; CONCANAVALIN A; CYTOCHALASIN D; IODINE 125; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; PHORBOL 13 ACETATE 12 MYRISTATE; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; ISOTOPE LABELING; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN DEGRADATION; TISSUE INJURY;

EID: 0036901565     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.LAB.0000041713.74852.2A     Document Type: Article

References (47)

1. Ailenberg M and Silverman M (1996). Cellular activation of mesangial gelatinase A by cytochalasin D is accompanied by enhanced mRNA expression of both gelatinase A and its membrane-associated gelatinase A activator (MT-MMP). Biochem J 313:879-884.
2. Birkedal-Hansen H, Moore WGI, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, and Engler JA (1993). Matrix metalloproteinases: A review. Crit Rev Oral Biol Med 42:197-250.
3. Brassart B, Randoux A, Hornebeck W, and Emonard H (1998). Regulation of matrix metalloproteinase-2 (gelatinase A, MMP-2), membrane-type matrix metalloproteinase-1 (MT1-MMP) and tissue inhibitor of metalloproteinase-2 (TIMP-2) expression by elastin-derived peptides in human HT-1080 fibrosarcoma cell fine. Clin Exp Metastasis 16:489-500.
4. Butler GS, Butler MJ, Atkinson SJ, Will H, Tamura T, van Westrum SS, Crabbe T, Clemens J, d'Ortho M-P, and Murphy G (1998). The TIMP-2 membrane type 1 metalloproteinase "receptor" regulates the concentration and efficiency of progelatinase A: A kinetic study. J Biol Chem 273:871-880.
5. Cao J, Drews M, Lee HM, Conner C, Bahou WF, and Zucker S (1998). The propeptide domain of membrane type I matrix metalloproteinase is required for binding of tissue inhibitor of metalloproteinases and for activation of pro-gelatinase A. J Biol Chem 273:34745-34752.
6. Cao J, Hymowitz M, Conner C, Bahou WF, and Zucker S (2000). The propeptide domain of membrane type 1-matrix metalloproteinase acts as an intramolecular chaperone when expressed in trans with the mature sequence in COS-1 cells. J Biol Chem 275:29648-29653.
7. Chan VT, Zhang DN, Nagaravapu U, Hultquist K, Romero LI, and Herron GS (1998). Membrane-type matrix metalloproteinases in human dermal microvascular endothelial cells: Expression and morphogenic correlation. J Invest Dermatol 11:1153-1159.
8. Clague MJ, Urbe S, Aniento F, and Gruenberg J (1994). Vacuolar ATPase activity is required for endosomal carrier vesicle formation. J Biol Chem 269:21-24.
9. Dery O, Thoma MS, Wong H, Grady EF, and Bunnett NW (1999). Trafficking of proteinase activated receptor-2 and β-arrestin-1 tagged with fluorescent protein: β-arrestin-1 dependent endocytosis of a proteinase receptor. J Biol Chem 274:18524-18535.
10. Durrbach A, Louvard D, and Coudrier E (1996). Actin filaments facilitate two steps of endocytosis. J Cell Sci 109:457-465.
11. Faltynek CR, Princler GL, Ruscetti FW, and Birchenall-Sparks M (1988). Lectins modulate the internalization of recombinant interferon-α and the induction of 2′.5′-oligo(A) synthetase. J Biol Chem 263:7112-7117.
12. Foda HD, George S, Conner C, Drews M, Tompkins DC, and Zucker S (1996). Activation of human umbilical vein endothelial cell progelatinase A by phorbol myristate acetate (PMA): A protein kinase C-dependent mechanism involving a membrane-type matrix metalloproteinase. Lab Invest 74: 538-545.
13. Gingras D, Page M, Annabi B, and Beliveau R (2000). Rapid activation of matrix metalloproteinase-2 by glioma cells occurs through a posttranslational MT1-MMP-dependent mechanism. Biochim Biophys Acta 1497:341-350.
14. Gottlieb TA, Ivanov IE, Adesnik M, and Sabatini DD (1993). Actin microfilaments play a critical role in endocytosis at the apical but not the basolateral surface of polarized epithelial cells. J Cell Biol 120:695-710.
15. Hernandez-Barrantes S, Toth M, Bernardo M, Yurkova M, Gervasi DC, Raz Y, Sang QA, and Fridman R (2000). Binding of active (57 kDa) membrane type-1 matrix metalloproteinase (MT1-MMP) to tissue inhibitor of metalloproteinase (TIMP)-2 regulates MT1-MMP processing and pro-MMP-2 activation. J Biol Chem 275:12080-12089.
16. Hiraoka N, Allen E, Apel IJ, Gyetko MR, and Weiss SJ (1998). Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins. Cell 95:365-377.
17. Hotary K, Allen E, Punturieri A, Yana I, and Weiss SJ (2000). Regulation of cell invasion and morphogenesis in a three-dimensional type I collagen matrix by membrane-type matrix metalloproteinases 1, 2, and 3. J Cell Biol 149:1309-1323.
18. Itoh Y, Ito A, Iwata K, Tanzawa K, Mori Y, and Nagase H (1998). Plasma membrane-bound tissue inhibitor of metalloproteinases (TIMP-2) specifically inhibits matrix metalloproteinase 2 (gelatinase A) activated on the cell surface. J Biol Chem 273:24360-24367.
19. Jiang A, Lehti K, Wang X, Weiss SJ, Keski-Oja J, and Pei D (2001). Regulation of membrane-type matrix metalloproteinase 1 activity by dynamin-mediated endocytosis. Proc Natl Acad Sci USA 98:13693-13698.
20. Koshikawa N, Giannelli G, Curculli V, Miyazaki K, and Qaranta V (2000). Role of surface metalloproteinase MT1-MMP in epithelial migration over laminin-5. J Cell Biol 148: 615-624.
21. Kurschat P, Zigrino P, Nischt R, Breitkreutz D, Steurer P, Klein EC, Krieg T, and Mauch C (1999). Tissue inhibitor of matrix metalloproteinase-2 regulates matrix metalloproteinase-2 activation by modulation of membrane-type 1 matrix metalloproteinase (MT1-MMP) activity in high and low invasive melanoma cells. J Biol Chem 274:21056-21062.
22. Lamaze C, Fujimoto M, Yin HL, and Schmid SL (1997). The actin cytoskeleton is required for receptor-mediated endocytosis in mammalian cells. J Biol Chem 272:20332-20335.
23. Lehti K, Lohi J, Valtanen H, and Keski-Qja J (1998). Proteolytic processing of membrane-type-1 matrix metalloproteinase is associated with gelatinase activation at the cell surface. Biochem J 334:345-353.
24. Li H, Bauzon DE, Xu X, Tschesche H, Cao J, and Sang QA. (1998) Immunological characterization of cell-surface and soluble forms of membrane type 1 matrix metalloproteinase in human breast cancer cells and in fibroblasts. Mol Carcinog 22:84-94.
25. Lohi J, Lehti K, Westermarck J, Kahari V-M, and Keski-Oja J (1996). Regulation of membrane-type matrix metalloproteinase-1 expression by growth factors and phorbol 12-myristate 13-acetate. Eur J Biochem 239:239-247.
26. Luttrell LM, Daaka Y, Della Rocca GJ, and Lefkowitz RJ (1997). G protein-coupled receptors mediate two functionally distinct pathways of tyrosine phosphorylation in rat 1a fibroblasts: Shc phosphorylation and receptor endocytosis correlate with activation of Erk kinases. J Biol Chem 272: 31648-31656.
27. Maquoi E, Frankenne F, Baramova E, Munaut C, Sounni NE, Remacle A, Noel A, Murphy G, and Foidart J-M (2000). Membrane type I matrix metalloproteinase-associated degradation of tissue inhibitor of metalloproteinase 2 in human tumor cell lines. J Biol Chem 275:11368-11378.
28. Murphy G, Knauper V, Atkinson S, Gavrilovic J, and Edwards D (2000). Cellular mechanisms for focal proteolysis and the regulation of the microenvironment. Fibrinolysis Proteolysis 14:165-174.
29. Nakahara H, Howard L, Thompson EW, Sato H, Seiki Y, Yeh Y, and Chen WT (1998). Transmembrane/cytoplasmic domain-mediated membrane type 1-matrix metalloproteinase docking to invadopodia is required for cell invasion. Proc Nati Acad Sci USA 94:7959-7964.
30. Ohuchi E, Imai K, Fuji Y, Sato H, Seiki M, and Okada Y (1997). Membrane type 1 matrix metalloproteinase digests interstitial collagens and other matrix macromolecules. J Biol Chem 272:2446-2451.
31. Okada A, Tomasetto C, Lutz Y, Bellocq J-P, Rio M-C, and Basset P (1997). Expression of matrix metalloproteinases during rat skin wound healing: Evidence that membrane type-1 matrix metalloproteinase is a stromal activator of pro-gelatinase A. J Cell Biol 137:67-77.
32. Overall CM and Sodek J (1990). Concanavalin A produces a matrix-degradative phenotype in human fibroblasts: Induction and endogenous activation of collagenase, 72-kDa gelatinase, and Pump-1 is accompanied by the suppression of tissue inhibitor of matrix metalloproteinases. J Biol Chem 265:21141-21151.
33. Pei D (1999). Identification and characterization of the fifth membrane-type matrix metalloproteinase MT5-MMP. J Biol Chem 274:8925-8932.
34. Pei D and Weiss SJ (1996). Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase process progelatinase A and express intrinsic matrix-degrading activity. J Biol Chem 271:9135-9140.
35. Peyroche A, Paris S, and Jackson CL (1996). Nucleotide exchange on ARF mediated by yeast Gea1 protein. Nature 384:479-481.
36. Rozanov DV, Deryugina EI, Ratnikov BI, Monosov EZ, Marchenko GN, Machenko GN, Quigley JP, and Strongin AY (2001). Mutation analysis of membrane type-1 matrix metalloproteinase (MT1-MMP): The role of the cytoplasmic tail Cys-574, the active site of Glu-240 and furin cleavage motifs in oligomerization, processing and self-proteolysis of MT1-MMP expressed in breast cancer. J Biol Chem: 276:25705-25714.
37. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, and Seiki M (1994). A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature 370:61-65.
38. Saurin AJ, Hamlett J, Clague MJ, and Pennington SR (1996). Inhibition of mitogen-induced DNA synthesis by bafilomycin A1 in Swiss 3T3 fibroblasts. Biochem J 313:65-70.
39. Shofuda K-I, Moriyama K, Kishihashi A, Higashi S, Mizushima H, Yasumitsu H, Miki K, Sato H, Seiki M, and Miyazaki K (1998). Role of tissue inhibitor of metalloproteinase-2 (TIMP-2) in regulation of progelatinase A activation catalyzed by membrane-type matrix metalloproteinase-1 (MT1-MMP) in human cancer cells. J Biochem 124:462-470.
40. Stanton H, Gavrilovic J, Atkinson S, d'Ortho M-P, Yamada KM, Zardi L, and Murphy G (1998). The activation of pro-MMP-2 (gelatinase A) by HT-1080 fibrosarcoma cells is promoted by culture on a fibronectin substrate and is concomitant with an increase in processing of MT1-MMP(MMP-14) to a 45 kDa form. J Cell Sci 111:2789-2798.
41. Strongin AY, Collier I, Bannicov G, Marmer BL, Grant GZ, and Goldberg GI (1995). Mechanism of cell surface activation of 72-kDa type IV collagenase: Isolation of the activated form of the membrane metalloproteinase. J Biol Chem 270:5331-5338.
42. Taub LM and Kornfeld S (1997). The trans-Golgi network: A late secretory sorting station. Curr Opin Cell Biol 9:527-533.
43. Toth M, Bernardo MM, Gervasi DC, Soloway P, Wang Z, Bigg HF, Overall CM, DeClerck YA, Tschesche H, Cher ML, Brown S, Mobashery S, and Fridman R (2000). Tissue inhibitor of metalloproteinase (TIMP)-2 acts synergistically with synthetic matrix metalloproteinase (MMP) inhibitors but not TIMP-4 to enhance the (Membrane type 1)-MMP-dependent activation of pro-MMP-2. J Biol Chem 275:41415-41423.
44. Vey M, Schafer W, Berghofer S, Klenk H-D, and Garten W (1993). Maturation of the trans-Golgi network furin: Compartmentalization of propeptide removal, substrate cleavage, and COOH terminal truncation. J Cell Biol 121:1829-1842.
45. Yu M, Bowden ET, Sitlani J, Sato H, Seiki M, Mueller SC, and Thompson EW (1998). Tyrosine phosphorylation mediates conA-induced membrane type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in MDA-MB-231 human breast carcinoma cells. Cancer Res 57:5028-5034.
46. Zucker S, Cao J, and Chen W-T (2000). Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment. Oncogene 19:6642-6650.
47. Zucker S, Drews M, Conner C, Foda HD, DeCLerck A, Langley KE, Bahou WF, Docherty AJP, and Cao J (1998). Tissue inhibitor of metalloproteinase-2 (TIMP-2) binds to the catalytic domain of the surface receptor, membrane type 1-matrix metalloproteinase 1 (MT1-MMP). J Biol Chem 273: 1216-1222.